American Journal of Cardiology
Volume 104, Issue 6 , Pages 786-790 , 15 September 2009

Comparison of Long Versus Short (“Spot”) Drug-Eluting Stenting for Long Coronary Stenoses

  • Demosthenes G. Katritsis, MD, PhD

      Affiliations

    • Department of Cardiology, Athens Euroclinic, Athens, Greece
    • Corresponding Author InformationCorresponding author: Tel: 0030-210-641-6600; fax: 0030-694-484-5505
    • ,
  • Socrates Korovesis, MD

      Affiliations

    • Department of Cardiology, Athens Euroclinic, Athens, Greece
    • ,
  • Efthalia Tzanalaridou, BSc

      Affiliations

    • Department of Cardiology, Athens Euroclinic, Athens, Greece
    • ,
  • Eleftherios Giazitzoglou, MD

      Affiliations

    • Department of Cardiology, Athens Euroclinic, Athens, Greece
    • ,
  • Eutychios Voridis, MD

      Affiliations

    • Department of Cardiology, Athens Euroclinic, Athens, Greece
    • ,
  • Bernhard Meier, MD

      Affiliations

    • Department of Cardiology, University Hospital, Bern, Switzerland

Received 3 March 2009 ,Revised 27 April 2009 ,Accepted 27 April 2009.

References 

  1. Bauters C, Hubert E, Prat A, Bougrimi K, Van Belle E, McFadden EP, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol. 1998;31:1291–1298
  2. Kobayashi Y, De Gregorio J, Kobayashi N, Akiyama T, Reimers B, Finci L, et al. Stented segment length as an independent predictor of restenosis. J Am Coll Cardiol. 1999;34:651–659
  3. Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Schömig A. Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol. 1999;83:1617–1622
  4. Kornowski R, Bhargava B, Fuchs S, Lansky AJ, Satler LF, Pichard AD, et al. Procedural results and late clinical outcomes after percutaneous interventions using long (> or = 25 mm) versus short (<20 mm) stents. J Am Coll Cardiol. 2000;35:612–618
  5. Colombo A, De Gregorio J, Moussa I, Kobayashi Y, Karvouni E, Di Mario C, et al. Intravascular ultrasound-guided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol. 2001;38:1427–1433
  6. Grewal J, Ganz P, Selwyn A, Kinlay S. Usefulness of intravascular ultrasound in preventing stenting of hazy areas adjacent to coronary stents and its support of support spot-stenting. Am J Cardiol. 2001;87:1246–1249
  7. Degertekin M, Arampatzis CA, Lemos PA, Saia F, Hoye A, Daemen J, et al. Very long sirolimus-eluting stent implantation for de novo coronary lesions. Am J Cardiol. 2004;93:826–829
  8. Tsagalou E, Chieffo A, Iakovou I, Ge L, Sangiorgi GM, Corvaja N, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol. 2005;45:1570–1573
  9. Muñoz JS, Abizaid A, Mintz GS, Albertal M, Abizaid AS, Feres F, et al. Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. Am J Cardiol. 2004;93:470–473
  10. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, et al. Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2006;67:595–599
  11. Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial. JAMA. 2006;295:1253–1263
  12. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
  13. Chieffo A, Bonizzoni E, Orlic D, Stankovic G, Rogacka R, Airoldi F, et al. Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents. Circulation. 2004;109:2732–2736
  14. Pinto Slottow TL, Steinberg DH, Roy PK, Buch AN, Okabe T, Xue Z, et al. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol. 2008;102:298–303
  15. Katritsis DG, Korovesis S, Karvouni E, Giazitzoglou E, Theodorou S, Kourlaba G, et al. Direct versus predilatation drug-eluting stenting: a randomized clinical trial. J Invasive Cardiol. 2006;18:475–479
  16. Kaski JC, Chen L, Chester M, Katritsis D. Rapid progression of coronary artery stenoses assessed by quantitative coronary angiography. Circulation. 1955;92:2058–2065
  17. Katritsis DG, Karabinos I, Papadopoulos A, Simeonidis P, Korovesis S, Giazitzoglou E, et al. Sustained ventricular tachycardia induced by dobutamine stress echocardiography: a prospective study. Europace. 2005;7:433–439
  18. Grube E, Dawkins KD, Guagliumi G, Banning AP, Zmudka K, Colombo A, et al. TAXUS IV 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesions. Eur Heart J. 2007;28:2578–2582
  19. Beohar N, Davidson CJ, Kip KE, Goodreau L, Vlachos HA, Meyers SN, et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA. 2007;297:1992–2000
  20. Schofer J, Schlüter M, Gershlick AH, Wijns W, Garcia E, Schampaert EBreithardt G E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
  21. Kang WC, Oh KJ, Han SH, Ahn TH, Chung WJ, Shin MS, et al. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents. Int J Cardiol. 2007;123:12–17
  22. Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, et al. Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:1563–1566
  23. Katritsis DG, Korovesis S, Karabinos I, Giazitzoglou E, Theodorou S, Karvouni E, et al. Sirolimus-versus paclitaxel-eluting stents: a comparison of two consecutive series in routine clinical practice. J Interv Cardiol. 2006;19:31–37
  24. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005;112:270–278
  25. Lim SY, Jeong MH, Hong SJ, Limdo S, Moon JY, Hong YJ, et al. Inflammation and delayed endothelization with overlapping drug-eluting stents in a porcine model of in-stent restenosis. Circ J. 2008;72:463–468
  26. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol. 2008;51:1844–1853
  27. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007;370:937–948
  28. Farb A, Boam AB. Stent thrombosis redux—the FDA perspective. N Engl J Med. 2007;356:984–987
  29. Brunner-La Rocca HP, Kaiser C, Bernheim A, Zellweger MJ, Jeger R, Buser PT, et al. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis. Lancet. 2007;370:1552–1559
  30. Hill RA, Boland A, Dickson R, Dündar Y, Haycox A, McLeod C, et al. Drug-eluting stents: a systematic review and economic evaluation. Health Technol Assess. 2007;11:iii, xi–221
  31. Mudra H, di Mario C, de Jaegere P, Figulla HR, Macaya C, Zahn R, et al. Randomized comparison of coronary stent implantation under ultrasound or angiographic guidance to reduce stent restenosis (OPTICUS study). Circulation. 2001;104:1343–1349

 Dr. Katritsis received research grants from Boston Scientific, Natick, Massachusetts, and Johnson and Johnson, Miami, Florida. Dr. Meier received research grants from Abbott Vascular, Santa Clara, California; Boston Scientific, Natick, Massachusetts; Johnson and Johnson, Miami, Florida; and Medtronic Inc., Minneapolis, Minnesota.

PII: S0002-9149(09)01042-X

doi: 10.1016/j.amjcard.2009.04.056

American Journal of Cardiology
Volume 104, Issue 6 , Pages 786-790 , 15 September 2009

Article Tools

* Image Usage & Resolution